Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial-Reference-Cited by-同舟云学术

Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial

Published:2020-06-30 Issue:2 Volume:29 Page:1103-1110
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Trinh Terry,Park Susanna B.,Murray Jenna,Pickering Hannah,Lin Cindy S.-Y.,Martin Andrew,Friedlander Michael,Kiernan Matthew C.,Goldstein David,Krishnan Arun V.

Funder

National Health and Medical Research Council

Cancer Institute NSW

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-020-05591-x.pdf

Reference45 articles.

1. McKeage MJ, Hsu T, Screnci D, Haddad G, Baguley BC (2001) Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 85(8):1219–1225. https://doi.org/10.1054/bjoc.2001.2024

2. Amptoulach S, Tsavaris N (2011) Neurotoxicity caused by the treatment with platinum analogues. Chemother Res Pract 2011:843019–843015. https://doi.org/10.1155/2011/843019

3. Cassidy J, Misset JL (2002) Oxaliplatin-related side effects: characteristics and management. Semin Oncol 29(5 Suppl 15):11–20. https://doi.org/10.1053/sonc.2002.35524

4. Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M, Alberti P, Bergamo F, Cortinovis D, Cazzaniga M, Santos C, Papadimitriou K, Kalofonos HP (2013) Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 119(2):438–444. https://doi.org/10.1002/cncr.27732

5. Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781. https://doi.org/10.1002/ana.24951

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study;Acta Oncologica;2023-08-30

2. Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment;European Journal of Medicinal Chemistry;2023-03

3. Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M);JNCI Cancer Spectrum;2022-10-29

4. Application of electrocatalytic effects of a newly synthesized monomer and graphene quantum dots to modify glassy carbon microelectrode as a sensor for determination of riluzole;Bulletin of Materials Science;2022-07-07

5. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders;Pharmaceuticals;2022-05-15